Millbrae, California
United States
13
2026-01-01
The entities that hold a legal rights for patent applications filed by inventor Chan Ivan:
Ivan Chan from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:
ENGINEERED IMMUNE CELLS WITH ENHANCED POTENCY AND USES OF SAME IN IMMUNOTHERAPY
#2 | 2025-11-06SELECTION OF OPTIMAL CELL DONORS AND METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF DONOR CELLS
#3 | 2025-09-25CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY
#4 | 2024-10-31GENETICALLY MODIFIED NATURAL KILLER CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY
#5 | 2024-10-10METHODS OF ENGINEERING IMMUNE CELLS FOR ENHANCED POTENCY AND PERSISTENCE AND USES OF ENGINEERED CELLS IN IMMUNOTHERAPY
#6 | 2023-12-07MULTIPLEX GENE EDITED CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY
#7 | 2022-12-29METHODS AND COMPOSITIONS FOR ENHANCED EXPANSION AND CYTOTOXICITY OF NATURAL KILLER CELLS
#8 | 2022-07-28COMBINATIONS OF ENGINEERED NATURAL KILLER CELLS AND ENGINEERED T CELLS FOR IMMUNOTHERAPY
#9 | 2022-07-28CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY
#10 | 2022-01-06Genetically modified natural killer cells for CD70-directed cancer immunotherapy
#11 | 2021-03-11Immune cells engineered to express CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
#12 | 2021-03-11CD19-directed chimeric antigen receptors and uses thereof in immunotherapy
#13 | 2021-03-04Cancer immunotherapy using CD19-directed chimeric antigen receptors
5013926 ⎘